Search research articles
Contact Us
Filters
Showing results (831-840 of 843) with videos related to
Page
of 85
Sort By:
Scientific Reports
|
July 8, 2017
Downregulation of ATG5-dependent macroautophagy by chaperone-mediated autophagy promotes breast cancer cell metastasis
Qi Han, Youcai Deng, Sha Chen, et al.
Inorganic Chemistry
|
January 24, 2023
Synthesis and Surface Attachment of Molecular Re(I) Complexes Supported by Functionalized Bipyridyl Ligands
Xiaofan Jia, Hannah S Nedzbala, Samuel R Bottum, et al.
The New Phytologist
|
March 21, 2024
An RRM domain protein SOE suppresses transgene silencing in rice
Rui Zhao, Wen-Ai Wu, Yi-Hua Huang, et al.
Oncogene
|
November 25, 2025
Prevention of cancer initiation by augmenting MHC-I antigen presentation via EZH2 inhibition
Wei Ding, Zihan Ding, Qinghong Zeng, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 2, 2010
Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2
Chu-Biao Xue, Anlai Wang, David Meloni, et al.
Plant Biotechnology Journal
|
September 4, 2025
Transcription Factor GmERFA Interacts With GmNFYA and Acts as a Negative Regulator of Seed Fatty Acid Accumulation in Soybean
Yue Liu, Yang Hu, Jun-Jie Wei, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 30, 2006
1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa
Donald J P Pinto, Michael J Orwat, Mimi L Quan, et al.
Journal of Integrative Plant Biology
|
August 14, 2025
The miR172a-ERF416/413 module regulates soybean seed traits
Meng Jin, Jia-Qi Han, Lu-Yao Zhang, et al.
Blood Cancer Journal
|
October 28, 2022
High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study
Jun Li, Qi Han, Yanqing Huang, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist
Chu-Biao Xue, Anlai Wang, Qi Han, et al.
Page
of 85
Search research articles
Search
Showing results (831-840 of 843) with videos related to
Sort By:
Page
of 85
Scientific Reports
|
July 8, 2017
Downregulation of ATG5-dependent macroautophagy by chaperone-mediated autophagy promotes breast cancer cell metastasis
Qi Han, Youcai Deng, Sha Chen, et al.
Inorganic Chemistry
|
January 24, 2023
Synthesis and Surface Attachment of Molecular Re(I) Complexes Supported by Functionalized Bipyridyl Ligands
Xiaofan Jia, Hannah S Nedzbala, Samuel R Bottum, et al.
The New Phytologist
|
March 21, 2024
An RRM domain protein SOE suppresses transgene silencing in rice
Rui Zhao, Wen-Ai Wu, Yi-Hua Huang, et al.
Oncogene
|
November 25, 2025
Prevention of cancer initiation by augmenting MHC-I antigen presentation via EZH2 inhibition
Wei Ding, Zihan Ding, Qinghong Zeng, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 2, 2010
Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2
Chu-Biao Xue, Anlai Wang, David Meloni, et al.
Plant Biotechnology Journal
|
September 4, 2025
Transcription Factor GmERFA Interacts With GmNFYA and Acts as a Negative Regulator of Seed Fatty Acid Accumulation in Soybean
Yue Liu, Yang Hu, Jun-Jie Wei, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 30, 2006
1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa
Donald J P Pinto, Michael J Orwat, Mimi L Quan, et al.
Journal of Integrative Plant Biology
|
August 14, 2025
The miR172a-ERF416/413 module regulates soybean seed traits
Meng Jin, Jia-Qi Han, Lu-Yao Zhang, et al.
Blood Cancer Journal
|
October 28, 2022
High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study
Jun Li, Qi Han, Yanqing Huang, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist
Chu-Biao Xue, Anlai Wang, Qi Han, et al.
Page
of 85